Fluence Energy is not worth touching unless its fundamentals are clearly amazing, and even then it could fail because manufacturing is hard. x.com 

Fluence Energy is bearish in the short term after its guidance cut, with the shares heading to new 52-week lows, though the long-term view remains bullish. x.com 

Fluence Energy's 14% drop on a 20M-share offering is overhang noise, not dilution, since the offering is a share unlock and transfer. About 97M more shares are now eligible for resale, creating short-term selling pressure, but the daily uptrend is intact above the 200-day EMA with strong inflows. Holding $21.75 keeps the structure intact, reclaiming $23-$23.80 resumes bullish momentum, and a break below $19.10 would mean reassessing everything. x.com 

Fluence Energy's 20% guidance cut reflects incompetent leadership, which is exactly why investing in leaders matters. Per @wallstengine, Fluence now expects fiscal 2026 revenue of about $2.4 billion, down from a roughly $3.0 billion midpoint, and an adjusted EBITDA loss near $200 million, blaming delays ramping its Houston contract manufacturing facility. The company says corrective actions have improved daily production and targets neutral to positive operating cash flow in fiscal 2027. x.com 

Fluence faces price pressure because its freely tradable float is expanding sharply while total shares stay the same. Even if the roughly 97 million shares are not sold right away, buyers won't chase knowing heavy selling could come at any time. The scarcity premium of a small float disappears as it widens, and more tradable shares also mean more stock to borrow for shorting. Fluence is a good company; the objection is to how this was handled. x.com 

Fluence Energy's $5.6B backlog exceeds its roughly $3.4B market cap by about 65%, so contracted future revenue is worth more than the business today, assuming execution holds. FY26 revenue guidance is $3.2-3.6B, and the backlog excludes a 12GW hyperscaler pipeline; announcing two hyperscaler deals in Q2 or Q3 could drive a bigger re-rating. Its software business, growing ARR 22% on top of the installed base, deserves at least 3x sales versus 0.5x for the whole company. x.com  x.com 

Fluence's story has shifted from massive demand to execution risk. Its first hyperscaler MSA finally converted into an $850M order, but production delays, quality issues and reduced guidance raised doubts about whether it can deliver. The stock lost its trend and broke every major support, a sign the market saw the change before anyone could explain it. x.com 

Fluence faces a material short-term overhang after management made about 117.7 million shares eligible for shelf-registered resale. The 20 million-share offering is an unlock and transfer, not dilution, but it leaves roughly 97 million more shares able to be sold, expanding the float and adding selling pressure. That creates a heavy psychological overhang even if nothing is sold; left alone, the stock could easily have doubled. The pending hyperscaler deals are what to watch. x.com  x.com 

Fluence Energy and Centrus Energy are not a late energy trade, because the US faces a large structural power deficit. Per Chamath Palihapitiya on the All-In podcast, by 2050 the US will be 2.5 Californias' worth of energy in deficit. x.com 

Eos Energy, Fluence and FuelCell Energy are best avoided because capital-intensive energy technology requires super-high capex. These small companies have no way to compete with industrial giants that have far greater borrowing power. Bloom Energy is the exception, with lower capitalization and a unique product delivered within 60-90 days of contract signing. x.com